Skip to main content
Journal cover image

FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.

Publication ,  Journal Article
Jimenez, J; Safranek, S; Viera, AJ
Published in: Am Fam Physician
August 1, 2007

Duke Scholars

Published In

Am Fam Physician

ISSN

0002-838X

Publication Date

August 1, 2007

Volume

76

Issue

3

Start / End Page

423 / 424

Location

United States

Related Subject Headings

  • Humans
  • General & Internal Medicine
  • Disease Progression
  • Diabetic Nephropathies
  • Diabetes Mellitus, Type 2
  • Clinical Trials as Topic
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin II Type 1 Receptor Blockers
  • 4203 Health services and systems
  • 1117 Public Health and Health Services
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Jimenez, J., Safranek, S., & Viera, A. J. (2007). FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy. Am Fam Physician, 76(3), 423–424.
Jimenez, Julio, Sarah Safranek, and Anthony J. Viera. “FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.Am Fam Physician 76, no. 3 (August 1, 2007): 423–24.
Jimenez J, Safranek S, Viera AJ. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy. Am Fam Physician. 2007 Aug 1;76(3):423–4.
Jimenez, Julio, et al. “FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy.Am Fam Physician, vol. 76, no. 3, Aug. 2007, pp. 423–24.
Jimenez J, Safranek S, Viera AJ. FPIN's clinical inquiries. Angiotensin blockade in patients with diabetic nephropathy. Am Fam Physician. 2007 Aug 1;76(3):423–424.
Journal cover image

Published In

Am Fam Physician

ISSN

0002-838X

Publication Date

August 1, 2007

Volume

76

Issue

3

Start / End Page

423 / 424

Location

United States

Related Subject Headings

  • Humans
  • General & Internal Medicine
  • Disease Progression
  • Diabetic Nephropathies
  • Diabetes Mellitus, Type 2
  • Clinical Trials as Topic
  • Angiotensin-Converting Enzyme Inhibitors
  • Angiotensin II Type 1 Receptor Blockers
  • 4203 Health services and systems
  • 1117 Public Health and Health Services